Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.
Results The study cohort included 20 388 propensity score matched pairs of new users initiating single inhaler triple therapy. Patients who received budesonide-glycopyrrolate-formoterol had a 9% ...
UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... in combination with inhaled corticosteroids (ICS), so ...
Here is the list of combination asthma inhalers currently licensed by the FDA: Asthma inhalers also differ based on how the drugs are delivered into your ... Choosing the right inhaler for your asthma ...
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
Medpage Today on MSN11d
Environmentally Friendlier COPD Inhaler May Also Be More EffectiveMetered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...
News Medical on MSN4d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback